B cell depletion therapies in autoimmune disease: advances and mechanistic insights

DSW Lee, OL Rojas, JL Gommerman - Nature reviews Drug discovery, 2021 - nature.com
In the past 15 years, B cells have been rediscovered to be not merely bystanders but rather
active participants in autoimmune aetiology. This has been fuelled in part by the clinical …

B cells in central nervous system disease: diversity, locations and pathophysiology

RW Jain, VW Yong - Nature Reviews Immunology, 2022 - nature.com
B cells represent a relatively minor cell population within both the healthy and diseased
central nervous system (CNS), yet they can have profound effects. This is emphasized in …

B cells in autoimmune and neurodegenerative central nervous system diseases

JJ Sabatino Jr, AK Pröbstel, SS Zamvil - Nature Reviews Neuroscience, 2019 - nature.com
B cells are essential components of the adaptive immune system and have important roles
in the pathogenesis of several central nervous system (CNS) diseases. Besides producing …

Reassessing B cell contributions in multiple sclerosis

R Li, KR Patterson, A Bar-Or - Nature immunology, 2018 - nature.com
There is growing recognition that B cell contributions to normal immune responses extend
well beyond their potential to become antibody-producing cells, including roles at the innate …

Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis

D Schafflick, CA Xu, M Hartlehnert, M Cole… - Nature …, 2020 - nature.com
Cerebrospinal fluid (CSF) protects the central nervous system (CNS) and analyzing CSF
aids the diagnosis of CNS diseases, but our understanding of CSF leukocytes remains …

Gut microbiota–specific IgA+ B cells traffic to the CNS in active multiple sclerosis

AK Pröbstel, X Zhou, R Baumann, S Wischnewski… - Science …, 2020 - science.org
Changes in gut microbiota composition and a diverse role of B cells have recently been
implicated in multiple sclerosis (MS), a central nervous system (CNS) autoimmune disease …

B‐cell Therapy for Multiple Sclerosis: Entering an era

AL Greenfield, SL Hauser - Annals of neurology, 2018 - Wiley Online Library
Monoclonal antibodies that target CD20 expressing B cells represent an important new
treatment option for patients with multiple sclerosis (MS). B‐cell‐depleting therapy is highly …

A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis

A Ramesh, RD Schubert… - Proceedings of the …, 2020 - National Acad Sciences
Central nervous system B cells have several potential roles in multiple sclerosis (MS):
secretors of proinflammatory cytokines and chemokines, presenters of autoantigens to T …

Genetic variation in the immunoglobulin heavy chain locus shapes the human antibody repertoire

OL Rodriguez, Y Safonova, CA Silver, K Shields… - Nature …, 2023 - nature.com
Variation in the antibody response has been linked to differential outcomes in disease, and
suboptimal vaccine and therapeutic responsiveness, the determinants of which have not …

IgD− CD27− double negative (DN) B cells: Origins and functions in health and disease

L Beckers, V Somers, J Fraussen - Immunology Letters, 2023 - Elsevier
Human B cells can be divided into four main subsets based on differential expression of
immunoglobulin (Ig) D and CD27. IgD− CD27− double negative (DN) B cells make up a …